Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2001
01/02/2001US6169181 Compounds useful to treat retroviral infections
01/02/2001US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives
01/02/2001US6169096 For inhibiting tumor growth in a mammal
01/02/2001US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye
01/02/2001US6169093 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
01/02/2001US6169088 1,3 diazines with platelet-derived growth factor receptor inhibitory activity
01/02/2001US6169086 Pyrazole derivatives
01/02/2001CA2068064C Fibrinogen receptor antagonists
01/02/2001CA2013449C Antibacterial 5-alkylquinolonecarboxylic acids
01/02/2001CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
01/02/2001CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use
12/2000
12/28/2000WO2000078757A1 Inhibitors of il-12 production
12/28/2000WO2000078756A1 Thiophene-ethyl thiourea compounds and their use in the treatment of hiv
12/28/2000WO2000078755A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000WO2000078749A1 Sulfonamide derivative as factor xa inhibitor
12/28/2000WO2000078748A1 Quinoline derivatives as antibacterials
12/28/2000WO2000078747A1 Acylhydrazine derivatives, process for preparing the same and use thereof
12/28/2000WO2000078746A1 Antiviral agents
12/28/2000WO2000078745A2 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole
12/28/2000WO2000078739A1 Pesticidally active tetrazine derivatives
12/28/2000WO2000078735A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
12/28/2000WO2000078733A1 Phenoxy fluoropyrimidines
12/28/2000WO2000078732A1 Halopyrimidines
12/28/2000WO2000078731A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000WO2000078730A1 Novel dihydropyrimidine derivatives
12/28/2000WO2000078728A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
12/28/2000WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use
12/28/2000WO2000078720A1 Novel dihydropyridine derivative
12/28/2000WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078317A1 Integrin receptor antagonists
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000049021A3 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000DE19929086A1 New pyrrole derivatives used as fungicides, bactericides and insecticides prepared e.g. from novel pyrrole acetic ester and methylation agent
12/28/2000DE19928424A1 New aminoacid residue substituted benzimidazole derivative I(kappa)B-kinase inhibitors, useful for treating NF(kappa)B-related disorders e.g. rheumatoid arthritis, asthma, Alzheimer's disease and cancer
12/28/2000DE19928306A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
12/28/2000DE19928281A1 Arylamino and aralkylamino substituted quinoline and quinazoline derivatives, useful for the treatment of e.g. tumors, pulmonary, respiratory and gastrointestinal disorders and psoriasis
12/28/2000CA2383492A1 Acylhydrazine derivatives, their production and use
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2376077A1 Integrin receptor antagonists
12/28/2000CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2375182A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000CA2373921A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
12/28/2000CA2341542A1 .alpha.1b-adrenergic receptor antagonists
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062205A2 Inhibitors of phospholipase enzymes
12/27/2000EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
12/27/2000EP1061921A1 Vitronectin receptor antagonists
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP0823900B1 Quinazoline derivatives
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0639050B1 Synergistic composition and process for selective weed control
12/27/2000CN1278258A Azaring-ether derivatives and their use as nicotinic ach receptor modulators
12/27/2000CN1278257A Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1059902C Estrogen excitant/antagonist
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166213 Omeprazole process and compositions thereof
12/26/2000US6166205 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
12/26/2000US6166088 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
12/26/2000US6166060 Antihistamines; sleep disorders; central nervous system disorders
12/26/2000US6166059 Thiocyano- triazolyl derivatives and their use as microbicides
12/26/2000US6166040 Treating a disorder of the central nervous system
12/26/2000US6166038 Aminopyrazole derivatives
12/26/2000US6166037 A blocking agent for blocking the entry of hiv into target cells of a patient to prevent infection of the patient by hiv
12/26/2000US6166035 1,4-dihydropyridine derivatives and their use in therapy
12/26/2000US6166028 Diaminopuridine-containing thiourea inhibitors of herpes viruses
12/26/2000US6166027 Treatment of high blood pressure and cardiac insufficiency, angina pectoris, arrhythmias, thromboembolic diseases, ischaemias, myocardial infarction, cerebral stroke, restenoses, coronary angioplasties, arteriosclerosis
12/26/2000US6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
12/26/2000US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives
12/26/2000US6166014 Treatment of disease-states characterized by thrombotic activity
12/26/2000US6166011 For treatment of disorders arising from neurodegenerative diseases or other disorders involving nerve damage
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165944 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
12/26/2000US6165941 Substituted 2-phenylpyridines
12/26/2000US6165729 Electrochemiluminescent reaction utilizing amine-derived reductant
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000077027A2 Serine protease inhibitors
12/21/2000WO2000077008A2 Heteroaryl substituted piperidines as gaba brain receptor lingands
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000076983A1 1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076982A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
12/21/2000WO2000076981A1 Piperidinyl and piperazinyl substituted benzofused lactams
12/21/2000WO2000076976A1 Process for the production of 2-pyridylpyridine derivatives
12/21/2000WO2000076975A1 Process for the production of 2-pyridylpyridine derivatives
12/21/2000WO2000076973A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076970A2 Serine protease inhibitors
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076966A2 Indolinylamide derivatives and the use thereof as antiviral drugs
12/21/2000WO2000076521A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000WO2000076514A1 Cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076512A1 Cyclopentyl modulators of chemokine receptor activity
1 ... 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 ... 1080